Chart pattern: Inverse Head and Shoulders (weekly)
▲ Broken out
Broke on Oct 30, 2026 · measured target $240.38 (+17%). Details →
Oct 27, 4:00 PM ET
Marsh & McLennan agreed on October 20, 2026 to sell €600 million of 4.250% senior notes due 2032 and €600 million of 4.625% senior notes due 2036 through underwriters, and the notes were issued on October 27, 2026. The filing is a debt financing that adds €1.2 billion of notes to the company's borrowings and does not report any change in earnings or guidance.
- €600 million of 4.250% Senior Notes due 2032 and €600 million of 4.625% Senior Notes due 2036 were sold under an October 20, 2026 underwriting agreement
- Notes were issued October 27, 2026 under a 2011 indenture with The Bank of New York Mellon as trustee, supplemented by a Twenty-Second Supplemental Indenture
- Notes were registered under a Form S-3 shelf filed July 24, 2024
Read the filing on SEC.gov ↗
Oct 15, 8:05 AM ET
Marsh reported third quarter 2026 results on October 15, 2026. Revenue rose 8% to $6.9 billion, or 5% on an underlying basis, and GAAP diluted EPS was $1.69 versus $1.51 a year earlier. Adjusted EPS rose 10% to $2.03, while nine-month GAAP diluted EPS fell to $6.68 from $6.75.
- Q3 2026 revenue was $6.9 billion, up 8% from $6.4 billion, or 5% on an underlying basis.
- Q3 GAAP diluted EPS was $1.69 versus $1.51; adjusted EPS rose 10% to $2.03.
- Nine-month GAAP diluted EPS was $6.68 versus $6.75; nine-month adjusted EPS rose 9% to $8.29.
- In Q3 the company repurchased 2.7 million shares for $500 million.
Read the filing on SEC.gov ↗
Jul 21, 7:02 AM ET
Marsh reported second quarter 2026 revenue of $7.4 billion, up 6% from a year earlier, with GAAP diluted EPS of $2.63 against $2.45 and adjusted EPS up 9% to $2.96. For the first six months, GAAP EPS fell to $4.99 from $5.23, a period that includes a $425 million Greensill litigation charge, while the Board raised the quarterly dividend 10% to $0.990 per share.
- Q2 2026 revenue $7.4 billion, up 6% (5% underlying); operating income up 4% to $1.9 billion
- Q2 GAAP diluted EPS $2.63 vs $2.45; adjusted EPS up 9% to $2.96
- Six-month GAAP diluted EPS $4.99 vs $5.23, including a $425 million Greensill litigation charge
- Board raised quarterly dividend 10% to $0.990 per share on July 8; repurchased $750 million of stock in Q2
Read the filing on SEC.gov ↗
Jun 3, 5:32 PM ET
On June 2, 2026, Marsh & McLennan entered into a new multi-currency unsecured $4.25 billion five-year revolving credit facility, expiring in June 2031, and terminated its existing $3.5 billion facility on the same day. The filing describes the new facility as larger than the one it replaces, with interest based on Term SOFR plus a margin tied to the company's credit ratings and quarterly coverage and leverage ratio requirements.
- New facility: multi-currency, unsecured, $4.25 billion, five-year revolving credit, expiring June 2031
- Terminated facility: $3.5 billion five-year revolving credit agreement dated October 11, 2023
- Interest rate: Term SOFR plus a fixed margin that varies with the company's credit ratings
- Covenants: certain coverage and leverage ratios tested quarterly; Citibank, N.A. is administrative agent
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.